End-Stage Renal Disease: Clinical Trials

1 trial for End-Stage Renal Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow End-Stage Renal Disease: new trials by email Literature Review of End-Stage Renal Disease trials Research Report on End-Stage Renal Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
Basiliximab, Cyclosporine, Tacrolimus - End-Stage Renal Disease
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)2742001-01-012016-10-21

Narrower conditions

Kidney Failure, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Basiliximab (1)  ·  Cyclosporine (1)  ·  Methylprednisolone (1)  ·  Prednisone (1)  ·  Sirolimus (1)  ·  Tacrolimus (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Mexico (1)  ·  United States (1)

Top investigators

William Harmon, MD (1)

Results publications

PMID 18416737, PMID 19663893